Showing results (141-150 of 157) with videos related to
Sort By:
Pageof 16
Archives of Otolaryngology--Head & Neck Surgery|May 1, 1997
Patterns of care for cancer of the larynx in the United StatesJ P Shah, L H Karnell, H T Hoffman, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|January 30, 2010
Transgenic expression of pancreatic secretory trypsin inhibitor-1 rescues SPINK3-deficient mice and restores a normal pancreatic phenotypeJoelle M-J Romac, Masaki Ohmuraya, Cathy Bittner, et al.International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinomaQuynh-Thu Le, David Tate, Albert Koong, et al.Cancer|March 15, 2006
Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomasQuynh-Thu Le, Al Taira, Sherie Budenz, et al.Journal of Leukocyte Biology|November 20, 2025
Differential roles for Irgm1 in myeloid cells for immune resistance to pathogenic bacteriaBrian E Fee, Lanette R Fee, Aemilia R Sprouse, et al.The Laryngoscope|August 1, 1997
Hypopharyngeal cancer patient care evaluationH T Hoffman, L H Karnell, J P Shah, et al.International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinomaWendy Hara, Billy W Loo, Don R Goffinet, et al.Molecular Cancer Therapeutics|September 4, 2007
The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases glioma proliferation and invasionAnita B Hjelmeland, Kathryn P Lattimore, Brian E Fee, et al.Respiratory Research|November 20, 2020
Treatment-related biomarkers in pulmonary hypertension patients on oral therapiesAparna C Swaminathan, Hongmei Zhu, Victor Tapson, et al.CNS Neuroscience & Therapeutics|February 4, 2014
AJAP1 is dysregulated at an early stage of gliomagenesis and suppresses invasion through cytoskeleton reorganizationLei Han, Kai-Liang Zhang, Jun-Xia Zhang, et al.Pageof 16